Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The mitochondrial inner membrane potential (ΔΨm) is the electrochemical gradient generated by the electron transport chain (ETC) across the inner mitochondrial membrane, serving as the primary driving force for ATP synthesis through oxidative phosphorylation (Mitchell, 1961). It plays a critical role in cellular homeostasis, including ion signaling, reactive oxygen species (ROS) production, and the regulation of programmed cell death (Perry et al., 2011, PubMed: 21779321). In oncology, many cancer cells exhibit mitochondrial hyperpolarization, which contributes to apoptosis resistance and metabolic reprogramming (Fantin et al., 2006, PubMed: 16775037). Conversely, mitochondrial depolarization is a hallmark of neurodegenerative conditions like Parkinson's and Alzheimer's diseases (Abramov et al., 2011, PubMed: 21295757). Therapeutic strategies targeting ΔΨm include the use of mitochondrial uncouplers to treat obesity and metabolic syndrome, or 'mitocans' to selectively induce apoptosis in malignant cells (Neuzil et al., 2013, PubMed: 23154438). However, because this potential is vital for all aerobic cells, pharmacological intervention carries significant risks of systemic toxicity and fatal hyperthermia (Grundlingh et al., 2011, PubMed: 21443419).
Drugs modulate ΔΨm by acting as protonophores that dissipate the proton gradient (uncoupling), inhibiting electron transport chain complexes (e.g., Complex I inhibition by Metformin), or modulating the mitochondrial permeability transition pore (mPTP) to trigger membrane depolarization and cytochrome c release (Zoratti & Szabo, 1995, PubMed: 7620158).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial inner membrane potential (ΔΨm) (ΔΨm).